Temat: "Amyloid" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Differential effects of familial Alzheimer's disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity.
Autorzy:: Schilling S; Department of Human Biology and Human Genetics, University of Kaiserslautern, 67663, Kaiserslautern, Germany.
Pradhan A; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Heesch A; Department of Human Biology and Human Genetics, University of Kaiserslautern, 67663, Kaiserslautern, Germany.
Helbig A; Department of Human Biology and Human Genetics, University of Kaiserslautern, 67663, Kaiserslautern, Germany.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Koch C; Department of Human Biology and Human Genetics, University of Kaiserslautern, 67663, Kaiserslautern, Germany.
Bertgen L; Department of Human Biology and Human Genetics, University of Kaiserslautern, 67663, Kaiserslautern, Germany.
Koo EH; San Diego (UCSD), Department of Neuroscience, University of California, La Jolla, CA, 92093-0662, USA.
Brinkmalm G; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.
Kins S; Department of Human Biology and Human Genetics, University of Kaiserslautern, 67663, Kaiserslautern, Germany.
Eggert S; Department of Human Biology and Human Genetics, University of Kaiserslautern, 67663, Kaiserslautern, Germany. .; Department of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, City-Campus, Hermann-Rein-Str. 3, 37075, Göttingen, Germany. .; Pokaż więcej
Źródło:: Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Jun 01; Vol. 11 (1), pp. 87. Date of Electronic Publication: 2023 Jun 01.
Typ publikacji:: Journal Article
MeSH Terms:: Amyloid beta-Protein Precursor*/genetics
Amyloid beta-Protein Precursor*/metabolism
Alzheimer Disease*/genetics
Alzheimer Disease*/metabolism
Humans ; Amyloid Precursor Protein Secretases/genetics ; Amyloid Precursor Protein Secretases/metabolism ; Amyloid beta-Peptides/metabolism ; Peptide Fragments/metabolism ; Mutation/genetics ; Presenilin-1/genetics

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: Different transmembrane domains determine the specificity and efficiency of the cleavage activity of the γ-secretase subunit presenilin.
Autorzy:: Schmidt FC; Biopolymer Chemistry, Technical University of Munich, Freising, Germany.
Fitz K; Biopolymer Chemistry, Technical University of Munich, Freising, Germany.
Feilen LP; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Okochi M; Neuropsychiatry, Division of Internal Medicine, Department of Integrated Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Steiner H; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), Ludwig-Maximilians-University, Munich, Germany.
Langosch D; Biopolymer Chemistry, Technical University of Munich, Freising, Germany. Electronic address: .; Pokaż więcej
Źródło:: The Journal of biological chemistry [J Biol Chem] 2023 May; Vol. 299 (5), pp. 104626. Date of Electronic Publication: 2023 Mar 20.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Amyloid Precursor Protein Secretases*/genetics
Amyloid Precursor Protein Secretases*/metabolism
Presenilin-1*/chemistry
Presenilin-1*/genetics
Presenilin-1*/metabolism
Presenilin-2*/chemistry
Presenilin-2*/genetics
Presenilin-2*/metabolism
Humans ; Alzheimer Disease/metabolism ; Amyloid beta-Peptides/genetics ; Amyloid beta-Peptides/metabolism ; Amyloid beta-Protein Precursor/metabolism ; Protein Domains

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 3.

Tytuł:: Membrane lipid remodeling modulates γ-secretase processivity.
Autorzy:: Dawkins E; Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), LMU Munich, Munich, Germany.
Derks RJE; Center for Proteomics & Metabolomics, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
Schifferer M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
Trambauer J; Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), LMU Munich, Munich, Germany.
Winkler E; Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), LMU Munich, Munich, Germany.
Simons M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany; Institute of Neuronal Cell Biology, Technical University Munich, Munich, Germany.
Paquet D; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany; Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.
Giera M; Center for Proteomics & Metabolomics, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
Kamp F; Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), LMU Munich, Munich, Germany.
Steiner H; Division of Metabolic Biochemistry, Faculty of Medicine, Biomedical Center (BMC), LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. Electronic address: .; Pokaż więcej
Źródło:: The Journal of biological chemistry [J Biol Chem] 2023 Apr; Vol. 299 (4), pp. 103027. Date of Electronic Publication: 2023 Feb 16.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Amyloid Precursor Protein Secretases*/genetics
Amyloid Precursor Protein Secretases*/metabolism
Alzheimer Disease*/genetics
Alzheimer Disease*/metabolism
Humans ; Membrane Lipids/metabolism ; Amyloid beta-Peptides/metabolism ; Cell Line ; Amyloid beta-Protein Precursor/metabolism ; Presenilin-1/metabolism

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 4.

Tytuł:: The mitochondria-targeted small molecule SS31 delays progression of behavioral deficits by attenuating β-amyloid plaque formation and mitochondrial/synaptic deterioration in APP/PS1 mice.
Autorzy:: Jia YL; Department of Graduate School, Hebei Medical University, Shijiazhuang, Hebei, 050051, China; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, 050051, China.
Wang W; Department of Electromyogram, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050051, China.
Han N; Department of Graduate School, Hebei Medical University, Shijiazhuang, Hebei, 050051, China.
Sun HL; Department of Graduate School, Hebei Medical University, Shijiazhuang, Hebei, 050051, China.
Dong FM; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, 050051, China.
Song YX; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, 050051, China.
Feng RF; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, 050051, China.
Wang JH; Department of Graduate School, Hebei Medical University, Shijiazhuang, Hebei, 050051, China; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei, 050051, China. Electronic address: .; Pokaż więcej
Źródło:: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2023 May 28; Vol. 658, pp. 36-43. Date of Electronic Publication: 2023 Feb 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Plaque, Amyloid*/drug therapy
Plaque, Amyloid*/metabolism
Alzheimer Disease*/drug therapy
Alzheimer Disease*/metabolism
Mice ; Animals ; Reactive Oxygen Species/metabolism ; Mice, Inbred C57BL ; Amyloid beta-Peptides/metabolism ; Mice, Transgenic ; Mitochondria/metabolism ; Antioxidants/pharmacology ; Disease Models, Animal ; Amyloid beta-Protein Precursor/genetics ; Amyloid beta-Protein Precursor/metabolism ; Presenilin-1/metabolism

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 5.

Tytuł:: APP mediates tau uptake and its overexpression leads to the exacerbated tau pathology.
Autorzy:: Chen J; Key Laboratory of Endemic and Ethnic Diseases, Laboratory of Molecular Biology, Ministry of Education, Guizhou Medical University, Guiyang, 550025, Guizhou, China.
Fan A; Guizhou Provincial Key Laboratory for Regenerative Medicine, Stem Cell and Tissue Engineering Research Center, Ministry of Education, Guizhou Medical University, Guiyang, 550025, Guizhou, China.
Li S; First Affiliated Hospital of Dalian Medical University, Dalian, 116021, Liaoning, China.
Xiao Y; Key Laboratory of Endemic and Ethnic Diseases, Laboratory of Molecular Biology, Ministry of Education, Guizhou Medical University, Guiyang, 550025, Guizhou, China.
Fu Y; Key Laboratory of Endemic and Ethnic Diseases, Laboratory of Molecular Biology, Ministry of Education, Guizhou Medical University, Guiyang, 550025, Guizhou, China.
Chen JS; Key Laboratory of Endemic and Ethnic Diseases, Laboratory of Molecular Biology, Ministry of Education, Guizhou Medical University, Guiyang, 550025, Guizhou, China.
Zi D; Department of Gynecology, Guizhou Provincial People's Hospital, Guiyang, 550025, Guizhou, China.
Zeng LH; Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, 310015, Zhejiang, China.
Tan J; Key Laboratory of Endemic and Ethnic Diseases, Laboratory of Molecular Biology, Ministry of Education, Guizhou Medical University, Guiyang, 550025, Guizhou, China. .; Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, 310015, Zhejiang, China. .; Pokaż więcej
Źródło:: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2023 Apr 18; Vol. 80 (5), pp. 123. Date of Electronic Publication: 2023 Apr 18.
Typ publikacji:: Journal Article
MeSH Terms:: Amyloid beta-Protein Precursor*/genetics
Amyloid beta-Protein Precursor*/metabolism
Alzheimer Disease*/metabolism
Mice ; Humans ; Animals ; tau Proteins/genetics ; tau Proteins/metabolism ; Disease Models, Animal ; Amyloid beta-Peptides/genetics ; Amyloid beta-Peptides/metabolism ; Mice, Transgenic

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 6.

Tytuł:: Cerebral Superficial Siderosis : Etiology, Neuroradiological Features and Clinical Findings.
Autorzy:: Weidauer S; Institute of Neuroradiology (1), Goethe University, Schleusenweg 2-16, 60528, Frankfurt am Main, Germany. .
Neuhaus E; Institute of Neuroradiology (1), Goethe University, Schleusenweg 2-16, 60528, Frankfurt am Main, Germany.
Hattingen E; Institute of Neuroradiology (1), Goethe University, Schleusenweg 2-16, 60528, Frankfurt am Main, Germany.; Pokaż więcej
Źródło:: Clinical neuroradiology [Clin Neuroradiol] 2023 Jun; Vol. 33 (2), pp. 293-306. Date of Electronic Publication: 2022 Nov 28.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Siderosis*/diagnostic imaging
Siderosis*/etiology
Cerebral Amyloid Angiopathy*/complications
Cerebral Amyloid Angiopathy*/diagnostic imaging
Humans ; Aged ; Amyloid beta-Peptides ; Magnetic Resonance Imaging ; Cerebral Hemorrhage ; Inflammation

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 7.

Tytuł:: Aquaporin 4 is differentially increased and dislocated in association with tau and amyloid-beta.
Autorzy:: Kecheliev V; Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland.
Boss L; Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland.
Maheshwari U; Department of Neurosurgery, Clinical Neuroscience Center, Zürich University Hospital, Zurich, Switzerland.
Konietzko U; Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland.
Keller A; Department of Neurosurgery, Clinical Neuroscience Center, Zürich University Hospital, Zurich, Switzerland; Zentrum für Neurowissenschaften Zurich, Zurich, Switzerland.
Razansky D; Zentrum für Neurowissenschaften Zurich, Zurich, Switzerland; Institute for Biomedical Engineering, ETH Zurich & University of Zurich, Zurich, Switzerland.
Nitsch RM; Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland; Zentrum für Neurowissenschaften Zurich, Zurich, Switzerland.
Klohs J; Institute for Biomedical Engineering, ETH Zurich & University of Zurich, Zurich, Switzerland.
Ni R; Institute for Regenerative Medicine, University of Zurich, Zurich, Switzerland; Zentrum für Neurowissenschaften Zurich, Zurich, Switzerland; Institute for Biomedical Engineering, ETH Zurich & University of Zurich, Zurich, Switzerland. Electronic address: .; Pokaż więcej
Źródło:: Life sciences [Life Sci] 2023 May 15; Vol. 321, pp. 121593. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:: Journal Article
MeSH Terms:: Alzheimer Disease*/metabolism
Amyloid beta-Peptides*/metabolism
Aquaporin 4*/genetics
Aquaporin 4*/metabolism
tau Proteins*/metabolism
Animals ; Mice ; Amyloid beta-Protein Precursor/metabolism ; Brain/metabolism ; Disease Models, Animal ; Mice, Transgenic ; Plaque, Amyloid/pathology

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 8.

Tytuł:: BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides.
Autorzy:: Zhou J; Department of Neuroscience, UConn Health, 263 Farmington Avenue, Farmington, CT, 06030-3401, USA.; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, 44195, United States.; Department of Neuroscience, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, United States.
Singh N; Department of Neuroscience, UConn Health, 263 Farmington Avenue, Farmington, CT, 06030-3401, USA.
Galske J; Department of Neuroscience, UConn Health, 263 Farmington Avenue, Farmington, CT, 06030-3401, USA.
Hudobenko J; Department of Neuroscience, UConn Health, 263 Farmington Avenue, Farmington, CT, 06030-3401, USA.
Hu X; Department of Neuroscience, UConn Health, 263 Farmington Avenue, Farmington, CT, 06030-3401, USA.
Yan R; Department of Neuroscience, UConn Health, 263 Farmington Avenue, Farmington, CT, 06030-3401, USA. .; Pokaż więcej
Źródło:: Molecular neurodegeneration [Mol Neurodegener] 2023 May 04; Vol. 18 (1), pp. 31. Date of Electronic Publication: 2023 May 04.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Alzheimer Disease*/metabolism
Amyloid beta-Peptides*/metabolism
Animals ; Mice ; Amyloid beta-Protein Precursor/metabolism ; Amyloid Precursor Protein Secretases/metabolism ; Aspartic Acid Endopeptidases/metabolism ; Astrocytes/metabolism ; Clusterin/metabolism ; Mice, Knockout ; Mice, Transgenic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Inhibition of NLRP1 inflammasome improves autophagy dysfunction and Aβ disposition in APP/PS1 mice.
Autorzy:: Li X; Department of Pharmacology, Basic Medicine College, Key Laboratory of Anti-Inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, 230032, China.
Zhang H; Department of Pharmacology, Basic Medicine College, Key Laboratory of Anti-Inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, 230032, China.
Yang L; Department of Pharmacology, Basic Medicine College, Key Laboratory of Anti-Inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, 230032, China.
Dong X; Department of Pharmacology, Basic Medicine College, Key Laboratory of Anti-Inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, 230032, China.
Han Y; Department of Pharmacology, Basic Medicine College, Key Laboratory of Anti-Inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, 230032, China.
Su Y; Department of Pharmacy, The First Affiliated Hospital of Anhui Medical University, Hefei, 230032, Anhui, China.
Li W; Department of Pharmacology, Basic Medicine College, Key Laboratory of Anti-Inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, 230032, China. .; Anqing Medical and Pharmaceutical College, Anqing, 246052, Anhui, China. .
Li W; Department of Pharmacology, Basic Medicine College, Key Laboratory of Anti-Inflammatory and Immunopharmacology, Ministry of Education, Anhui Medical University, Hefei, 230032, China. .; Pokaż więcej
Źródło:: Behavioral and brain functions : BBF [Behav Brain Funct] 2023 Apr 13; Vol. 19 (1), pp. 7. Date of Electronic Publication: 2023 Apr 13.
Typ publikacji:: Journal Article
MeSH Terms:: Amyloid beta-Peptides*/metabolism
Amyloid beta-Peptides*/pharmacology
Alzheimer Disease*/genetics
Alzheimer Disease*/metabolism
Alzheimer Disease*/pathology
Mice ; Animals ; Amyloid beta-Protein Precursor/genetics ; Amyloid beta-Protein Precursor/metabolism ; Amyloid beta-Protein Precursor/pharmacology ; Inflammasomes/metabolism ; Inflammasomes/pharmacology ; Amyloid Precursor Protein Secretases/pharmacology ; NLR Proteins ; AMP-Activated Protein Kinases/pharmacology ; Mice, Transgenic ; Aspartic Acid Endopeptidases/pharmacology ; Autophagy ; TOR Serine-Threonine Kinases/metabolism ; TOR Serine-Threonine Kinases/pharmacology ; Disease Models, Animal

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities.
Autorzy:: Brandimarti R; Department of Pharmacology and Physiology, Drexel University College of Medicine, 245 N.15th Street, Philadelphia, PA, 19102, USA.; Center for Neuroimmunology and CNS Therapeutics, Drexel University College of Medicine, 245 N.15th Street, Philadelphia, PA, 19102, USA.; Department of Pharmacy and Biotechnology, University of Bologna, Via San Giacomo,14, 40126, Bologna, Italy.
Irollo E; Department of Pharmacology and Physiology, Drexel University College of Medicine, 245 N.15th Street, Philadelphia, PA, 19102, USA.; Center for Neuroimmunology and CNS Therapeutics, Drexel University College of Medicine, 245 N.15th Street, Philadelphia, PA, 19102, USA.
Meucci O; Department of Pharmacology and Physiology, Drexel University College of Medicine, 245 N.15th Street, Philadelphia, PA, 19102, USA. .; Center for Neuroimmunology and CNS Therapeutics, Drexel University College of Medicine, 245 N.15th Street, Philadelphia, PA, 19102, USA. .; Department of Microbiology and Immunology, Drexel University College of Medicine, 245 N.15th Street, Philadelphia, PA, 19102, USA. .; Pokaż więcej
Źródło:: Molecular neurobiology [Mol Neurobiol] 2023 Apr; Vol. 60 (4), pp. 1811-1825. Date of Electronic Publication: 2022 Dec 28.
Typ publikacji:: Journal Article
MeSH Terms:: Amyloid beta-Protein Precursor*/metabolism
Alzheimer Disease*/metabolism
Humans ; Amyloid Precursor Protein Secretases/metabolism ; Amyloid beta-Peptides/metabolism ; Neurons/metabolism ; Protein Transport

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 11.

Tytuł:: Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy.
Autorzy:: de Kort AM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands.
Kuiperij HB; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands.
Jäkel L; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands.
Kersten I; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands.
Rasing I; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
van Etten ES; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
van Rooden S; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
van Osch MJP; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
Wermer MJH; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Terwindt GM; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Schreuder FHBM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands.
Klijn CJM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands.
Verbeek MM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Radboud Alzheimer Centre, P.O. Box 9101, Nijmegen, 6500 HB, The Netherlands. .; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. .; Pokaż więcej
Źródło:: Alzheimer's research & therapy [Alzheimers Res Ther] 2023 Jun 03; Vol. 15 (1), pp. 102. Date of Electronic Publication: 2023 Jun 03.
Typ publikacji:: Journal Article
MeSH Terms:: Cerebral Amyloid Angiopathy*/diagnostic imaging
Alzheimer Disease*/diagnosis
Humans ; Amyloid beta-Peptides ; Peptide Fragments ; Biomarkers

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 12.

Tytuł:: Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
Autorzy:: De Kort AM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands.
Kuiperij HB; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands.
Marques TM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands.
Jäkel L; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands.
van den Berg E; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands.
Kersten I; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands.
van Berckel-Smit HEP; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands.
Duering M; Medical Image Analysis Center and Qbig, Department of Biomedical Engineering, University of Basel, Basel, Switzerland.
Stoops E; ADx NeuroSciences, Ghent, Belgium.
Abdo WF; Department of Intensive Care, Radboud University Medical Center, Nijmegen, the Netherlands.
Rasing I; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Voigt S; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Koemans EA; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Kaushik K; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Warren AD; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Greenberg SM; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Brinkmalm G; Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, and Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Terwindt GM; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Wermer MJH; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Schreuder FHBM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands.
Klijn CJM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands.
Verbeek MM; Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition, and Behavior, Nijmegen, the Netherlands.; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.; Pokaż więcej
Źródło:: Annals of neurology [Ann Neurol] 2023 Jun; Vol. 93 (6), pp. 1173-1186. Date of Electronic Publication: 2023 Feb 20.
Typ publikacji:: Journal Article
MeSH Terms:: Cerebral Amyloid Angiopathy, Familial*
Cerebral Amyloid Angiopathy*
Alzheimer Disease*/diagnosis
Alzheimer Disease*/cerebrospinal fluid
Humans ; Amyloid beta-Peptides/cerebrospinal fluid ; Peptide Fragments/cerebrospinal fluid ; Biomarkers/cerebrospinal fluid

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 13.

Tytuł:: Bifunctional cysteine gold nanoclusters for β-amyloid fibril inhibition and fluorescence imaging: a distinctive approach to manage Alzheimer's disease.
Autorzy:: Resmi AN; Division of Biophotonics and Imaging, Department of Biomaterial Sciences and Technology, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum 695012, India. .
Rekha CR; Division of Biophotonics and Imaging, Department of Biomaterial Sciences and Technology, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum 695012, India. .
Dhushyandhun ME; Division of Biophotonics and Imaging, Department of Biomaterial Sciences and Technology, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum 695012, India. .
Elangovan S; Division of Biophotonics and Imaging, Department of Biomaterial Sciences and Technology, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum 695012, India. .
Shenoy SJ; Division of in vivo Models and Testing, Department of Applied Biology, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum 695012, India.
Gulia KK; Division of Sleep Research, Department of Applied Biology, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum 695012, India.
Jayasree RS; Division of Biophotonics and Imaging, Department of Biomaterial Sciences and Technology, Biomedical Technology Wing, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum 695012, India. .; Pokaż więcej
Źródło:: Journal of materials chemistry. B [J Mater Chem B] 2023 May 31; Vol. 11 (21), pp. 4715-4724. Date of Electronic Publication: 2023 May 31.
Typ publikacji:: Journal Article
MeSH Terms:: Amyloid beta-Peptides*/metabolism
Alzheimer Disease*/diagnostic imaging
Alzheimer Disease*/drug therapy
Alzheimer Disease*/metabolism
Animals ; Cysteine ; Amyloid/chemistry ; Plaque, Amyloid ; Gold/chemistry ; Molecular Docking Simulation ; Sulfur/therapeutic use

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 14.

Tytuł:: Phenotype and imaging features associated with APP duplications.
Autorzy:: Grangeon L; Department of Neurology and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France. .; Department of Neurology, Rouen University Hospital, Rouen Cedex, 76031, France. .
Charbonnier C; Department of Genetics and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.
Zarea A; Department of Neurology and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.
Rousseau S; Department of Genetics and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.
Rovelet-Lecrux A; Department of Genetics and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.
Bendetowicz D; Neurology Department, Sorbonne Université, Paris Brain Institute - ICM, Inserm, CNRS and APHP, Hôpital de la Pitié-Salpétrière APHP, Paris, France.
Lemaitre M; Geriatric department, Seclin-Carvin Hospital, Seclin, France.
Malrain C; Department of Neurology, Rennes Hospital, Rennes, France.
Quillard-Muraine M; Laboratoire de biochimie, Rouen University Hospital and University of Rouen, Rouen, France.
Cassinari K; Department of Genetics and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.
Maltete D; Department of Neurology and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.
Pariente J; Neurology Department, Toulouse University Hospital and Toulouse NeuroImaging Center (ToNIC) INSERM-Univeristy of Toulouse Paul Sabatier, Toulouse, France.
Moreaud O; Department of Neurology, Grenoble Hospital, Grenoble, France.
Magnin E; Department of Neurology, Besancon Hospital, Besancon, France.
Cretin B; Department of Neurology, Hautepierre Hospital, Strasbourg, France.
Mackowiak MA; Univ. Lille, CHU Lille, CNRMAJ, 59000, Lille, France.
Sillaire AR; Univ. Lille, CHU Lille, CNRMAJ, 59000, Lille, France.
Vercelletto M; Department of Neurology, Nantes University Hospital, Nantes, France.
Dionet E; Department of Neurology, Clermont-Ferrand Hospital, Clermont-Ferrand, France.
Felician O; APHM, Service de Neurologie et Neuropsychologie, CHU Timone, Marseille, France.; Aix Marseille Univ, INSERM, INS, Inst Neurosci Syst, Marseille, France.
Rod-Olivieri P; Neurology Department, Hôpital Saint Anne APHP, Paris, France.
Thomas-Antérion C; Department of Neurology, Lyon University Hospital, Lyon, France.
Godeneche G; Department of Neurology, La Rochelle Hospital, La Rochelle, France.
Sauvée M; Department of Neurology, Grenoble Hospital, Grenoble, France.
Cartz-Piver L; Centre Mémoire Ressources et Recherche (CMRR), Limoges University Hospital, Limoges, France.
Le Ber I; Neurology Department, Sorbonne Université, Paris Brain Institute - ICM, Inserm, CNRS and APHP, Hôpital de la Pitié-Salpétrière APHP, Paris, France.
Chauvire V; Department of Neurology, Angers University Hospital, Angers, France.
Jonveaux T; Department of Neurology, Nancy University Hospital, Nancy, France.
Balageas AC; CHRU Tours, Centre Mémoire Ressources et Recherche (CMRR), Tours, France.
Laquerriere A; Department of Neuropathology, F 76000, Normandy Center for Genomic and Personalized Medicine, Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Rouen, France.
Duyckaerts C; Sorbonne Unviersité, INSERM, CNRS U1127, ICM and Laboratoire de Neuropathologie R. Escourolle, Hospital Pitie-Salpêtrière, Paris, France.
Vital A; Department of Pathology, University Hospital, Bordeaux, France.
de Paula AM; Department of Pathology, La Timone University Hospital, Marseille, France.
Meyronet D; Department of Pathology, Hopital Civil University Hospital, Lyon, France.
Guyant-Marechal L; Department of Genetics and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.
Hannequin D; Department of Neurology and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.
Tournier-Lasserve E; AP-HP, Groupe Hospitalier Saint-Louis Lariboisière-Fernand-Widal, Service de Génétique Moléculaire Neurovasculaire, INSERM UMR 1141, NeuroDiderot, Université de Paris, Paris, France.
Campion D; Department of Genetics and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.
Nicolas G; Department of Genetics and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.
Wallon D; Department of Neurology and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.; Pokaż więcej
Corporate Authors:: CNR-MAJ collaborators
Źródło:: Alzheimer's research & therapy [Alzheimers Res Ther] 2023 May 11; Vol. 15 (1), pp. 93. Date of Electronic Publication: 2023 May 11.
Typ publikacji:: Journal Article
MeSH Terms:: Alzheimer Disease*/diagnostic imaging
Alzheimer Disease*/genetics
Alzheimer Disease*/complications
Cerebral Amyloid Angiopathy*/diagnostic imaging
Cerebral Amyloid Angiopathy*/genetics
Cerebral Amyloid Angiopathy*/complications
Humans ; Amyloid/genetics ; Cerebral Hemorrhage/complications ; Cerebral Hemorrhage/genetics ; Cerebral Hemorrhage/pathology ; Magnetic Resonance Imaging ; Phenotype ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Brain p3-Alcβ peptide restores neuronal viability impaired by Alzheimer's amyloid β-peptide.
Autorzy:: Hata S; Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.; Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Japan.
Saito H; Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.; Advanced Prevention and Research Laboratory for Dementia, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Kakiuchi T; Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Japan.
Fukumoto D; Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Japan.
Yamamoto S; Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Japan.
Kasuga K; Molecular Genetics, Niigata University Brain Research Institute, Nigata, Japan.
Kimura A; Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Moteki K; Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.; Advanced Prevention and Research Laboratory for Dementia, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Abe R; Advanced Prevention and Research Laboratory for Dementia, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Adachi S; Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tokyo, Japan.
Kinoshita S; Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.; Advanced Prevention and Research Laboratory for Dementia, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Yoshizawa-Kumagaye K; Peptide Institute, Inc., Ibaraki, Japan.
Nishio H; Peptide Institute, Inc., Ibaraki, Japan.
Saito T; Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science Institute, Wako, Japan.; Department of Neurocognitive Science, Institute of Brain Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Saido TC; Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science Institute, Wako, Japan.
Yamamoto T; Department of Molecular Neurobiology, Factory of Medicine, Kagawa University, Takamatsu, Japan.
Nishimura M; Molecular Neuroscience Research Center, Shiga University of Medical Science, Shiga, Japan.
Taru H; Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.; Advanced Prevention and Research Laboratory for Dementia, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Sobu Y; Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.; Advanced Prevention and Research Laboratory for Dementia, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Ohba H; Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Japan.
Nishiyama S; Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Japan.
Harada N; Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Japan.
Ikeuchi T; Molecular Genetics, Niigata University Brain Research Institute, Nigata, Japan.
Tsukada H; Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Japan.
Ouchi Y; Department of Biofunctional Imaging, Preeminent Medical Education & Research Center, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Suzuki T; Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.; Advanced Prevention and Research Laboratory for Dementia, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.; Pokaż więcej
Źródło:: EMBO molecular medicine [EMBO Mol Med] 2023 May 08; Vol. 15 (5), pp. e17052. Date of Electronic Publication: 2023 Mar 30.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Amyloid beta-Peptides*/metabolism
Alzheimer Disease*/drug therapy
Alzheimer Disease*/metabolism
Mice ; Animals ; Humans ; Amyloid beta-Protein Precursor/genetics ; Amyloid beta-Protein Precursor/metabolism ; Brain/metabolism ; Neurons/metabolism ; Amyloid Precursor Protein Secretases/metabolism

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 16.

Tytuł:: How Single Site Mutations Can Help Understanding Structure Formation of Amyloid β 1-40 .
Autorzy:: Schwarze B; Institute for Medical Physics and Biophysics, University of Leipzig, Härtelstr. 16/18, D-04107, Leipzig, Germany.
Huster D; Institute for Medical Physics and Biophysics, University of Leipzig, Härtelstr. 16/18, D-04107, Leipzig, Germany.; Pokaż więcej
Źródło:: Macromolecular bioscience [Macromol Biosci] 2023 May; Vol. 23 (5), pp. e2200489. Date of Electronic Publication: 2023 Mar 10.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Amyloid beta-Peptides*/chemistry
Alzheimer Disease*/metabolism
Humans ; Amyloid/genetics ; Amyloid/metabolism ; Peptide Fragments/chemistry ; Mutation

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 17.

Tytuł:: Independent study demonstrates amyloid probability score accurately indicates amyloid pathology.
Autorzy:: Fogelman I; C2N Diagnostics, St. Louis, Missouri, USA.
West T; C2N Diagnostics, St. Louis, Missouri, USA.
Braunstein JB; C2N Diagnostics, St. Louis, Missouri, USA.
Verghese PB; C2N Diagnostics, St. Louis, Missouri, USA.
Kirmess KM; C2N Diagnostics, St. Louis, Missouri, USA.
Meyer MR; C2N Diagnostics, St. Louis, Missouri, USA.
Contois JH; C2N Diagnostics, St. Louis, Missouri, USA.
Shobin E; Biogen, Cambridge, Massachusetts, USA.
Ferber KL; Biogen, Cambridge, Massachusetts, USA.
Gagnon J; Biogen, Cambridge, Massachusetts, USA.
Rubel CE; Biogen, Cambridge, Massachusetts, USA.
Graham D; Biogen, Cambridge, Massachusetts, USA.
Bateman RJ; Dept. of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Tracey Family SILQ Center, Washington University School of Medicine, St. Louis, Missouri, USA.
Holtzman DM; Dept. of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Tracey Family SILQ Center, Washington University School of Medicine, St. Louis, Missouri, USA.
Huang S; Stat4ward, Pittsburgh, Pennsylvania, USA.
Yu J; Stat4ward, Pittsburgh, Pennsylvania, USA.
Yang S; Stat4ward, Pittsburgh, Pennsylvania, USA.
Yarasheski KE; C2N Diagnostics, St. Louis, Missouri, USA.; Pokaż więcej
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2023 May; Vol. 10 (5), pp. 765-778. Date of Electronic Publication: 2023 Mar 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Amyloid beta-Peptides*
Alzheimer Disease*/diagnostic imaging
Alzheimer Disease*/pathology
Humans ; Middle Aged ; Aged ; Plaque, Amyloid/diagnostic imaging ; Australia ; Aging/pathology ; Amyloid

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Inhibition of the Fibrillation of Amyloid Aβ 1-40 by Hybrid-Lipid-Polymer Vesicles.
Autorzy:: Sen N; Macromolecular Chemistry, Institute of Chemistry, Faculty of Natural Science II (Chemistry, Physics and Mathematics)Martin Luther University Halle-Wittenberg, von-Danckelmann-Platz 4, D-06120, Halle, Germany.
Haupt C; Biophysical Chemistry, Institute of Chemistry and Charles-Tanford Protein Center, Martin Luther University of Halle-Wittenberg, 06120, Halle (Saale), Germany.
Hause G; Biocenter, Martin-Luther University Halle-Wittenberg, Weinbergweg 22, D-06120, Halle (Saale), Germany.
Bacia K; Biophysical Chemistry, Institute of Chemistry and Charles-Tanford Protein Center, Martin Luther University of Halle-Wittenberg, 06120, Halle (Saale), Germany.
Binder WH; Macromolecular Chemistry, Institute of Chemistry, Faculty of Natural Science II (Chemistry, Physics and Mathematics)Martin Luther University Halle-Wittenberg, von-Danckelmann-Platz 4, D-06120, Halle, Germany.; Pokaż więcej
Źródło:: Macromolecular bioscience [Macromol Biosci] 2023 May; Vol. 23 (5), pp. e2200522. Date of Electronic Publication: 2023 Mar 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Amyloid beta-Peptides*/chemistry
Polymers*/chemistry
Humans ; Glycerol ; Amyloid/chemistry ; Amyloid/metabolism ; Lipids ; Cholesterol/chemistry

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 19.

Tytuł:: Role of mass spectrometry in the study of interactions between amylin and metal ions.
Autorzy:: Moracci L; Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.; Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy.
Crotti S; Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.; Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy.
Traldi P; Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy.
Agostini M; Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, Padova, Italy.; Fondazione Istituto di Ricerca Pediatrica Città della Speranza, Padova, Italy.
Cosma C; Department of Medicine, University of Padova, Padova, Italy.
Lapolla A; Department of Medicine, University of Padova, Padova, Italy.; Pokaż więcej
Źródło:: Mass spectrometry reviews [Mass Spectrom Rev] 2023 May; Vol. 42 (3), pp. 984-1007. Date of Electronic Publication: 2021 Sep 24.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Islet Amyloid Polypeptide*/chemistry
Islet Amyloid Polypeptide*/metabolism
Insulins*
Mice ; Humans ; Animals ; Copper/chemistry ; Copper/metabolism ; Spectrometry, Mass, Electrospray Ionization ; Amyloid/chemistry ; Amyloid/metabolism ; Glucose

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 20.

Tytuł:: Investigating New Applications of a Photoswitchable Fluorescent Norbornadiene as a Multifunctional Probe for Delineation of Amyloid Plaque Polymorphism.
Autorzy:: Dreos A; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, 43180 Mölndal, Sweden.; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma Bionand, 29590 Malaga, Spain.
Ge J; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, 43180 Mölndal, Sweden.
Najera F; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma Bionand, 29590 Malaga, Spain.; Departamento de Química Orgánica, Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain.
Tebikachew BE; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296 Gothenburg, Sweden.
Perez-Inestrosa E; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma Bionand, 29590 Malaga, Spain.; Departamento de Química Orgánica, Facultad de Ciencias, Universidad de Málaga, 29071 Málaga, Spain.
Moth-Poulsen K; Department of Chemistry and Chemical Engineering, Chalmers University of Technology, 41296 Gothenburg, Sweden.; Institute of Materials Science of Barcelona, ICMAB-CSIC, Bellaterra, 08193 Barcelona, Spain.; Catalan Institution for Research and Advanced Studies ICREA, Pg. Lluís Companys 23, 08010 Barcelona, Spain.; Department of Chemical Engineering, Universitat Politecnica de Catalunya, EEBE, Eduard Maristany 10-14, 08019 Barcelona, Spain.
Blennow K; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, 43180 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 43180 Mölndal, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, 43180 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 43180 Mölndal, Sweden.; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.; UK Dementia Research Institute, University College London, London WC1N 3BG, UK.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong 1512-1518, China.; UW Department of Medicine, School of Medicine and Public Health, Madison, Wisconsin 53726, United States.
Hanrieder J; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy, University of Gothenburg, 43180 Mölndal, Sweden.; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London WC1N 3BG, UK.; Pokaż więcej
Źródło:: ACS sensors [ACS Sens] 2023 Apr 28; Vol. 8 (4), pp. 1500-1509. Date of Electronic Publication: 2023 Mar 22.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Amyloid beta-Peptides*/chemistry
Alzheimer Disease*/diagnostic imaging
Alzheimer Disease*/pathology
Mice ; Animals ; Plaque, Amyloid/pathology ; Disease Models, Animal ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods ; Mice, Transgenic ; Fluorescent Dyes

Czasopismo naukowe

na półce

Szczegóły

Informacja

Wyszukujesz frazę ""Amyloid"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język